|
Name |
Dodecenylsuccinic anhydride
|
Molecular Formula | C16H26O3 | |
IUPAC Name* |
3-[(E)-dodec-1-enyl]oxolane-2,5-dione
|
|
SMILES |
CCCCCCCCCC/C=C/C1CC(=O)OC1=O
|
|
InChI |
InChI=1S/C16H26O3/c1-2-3-4-5-6-7-8-9-10-11-12-14-13-15(17)19-16(14)18/h11-12,14H,2-10,13H2,1H3/b12-11+
|
|
InChIKey |
WVRNUXJQQFPNMN-VAWYXSNFSA-N
|
|
Synonyms |
DODECENYLSUCCINIC ANHYDRIDE; 25377-73-5; 2,5-Furandione, 3-(dodecenyl)dihydro-; DDSA; 3-[(E)-dodec-1-enyl]oxolane-2,5-dione; ALQ23WB445; 3-[(1E)-dodec-1-en-1-yl]oxolane-2,5-dione; n-Dodecenylsuccinic anhydride; 1-dodecenylsuccinic anhydride; 119295-58-8; 2,5-Furandione, 3-(1-dodecenyl)dihydro-, (E)-; 19532-92-4; Rikacid DDSA; K 12 (anhydride); Dodecenyl succinic anhydride; CCRIS 698; 2-(Dodecyl)succinic anhydride; Succinic anhydride, dodecenyl-; Dodecenylsuccinic acid anhydride; HSDB 4374; EINECS 246-917-1; UNII-ALQ23WB445; SCHEMBL107779; DTXSID80893538; 2-(1-Dodecenyl)succinic anhydride; AKOS015912885; NCGC00164187-02; AS-81577; 2,5-Furandione, 3-(dodecen-1-yl)dihydro-; (E)-3-(dodec-1-enyl)dihydrofuran-2,5-dione; 3-[(1E)-1-Dodecen-1-yl]dihydro-2,5-furandione; W-109191
|
|
CAS | 25377-73-5 | |
PubChem CID | 6433892 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 266.38 | ALogp: | 5.4 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 43.4 | Aromatic Rings: | 1 |
Heavy Atoms: | 19 | QED Weighted: | 0.248 |
Caco-2 Permeability: | -4.834 | MDCK Permeability: | 0.00002620 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.009 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.96 |
30% Bioavailability (F30%): | 0.974 |
Blood-Brain-Barrier Penetration (BBB): | 0.218 | Plasma Protein Binding (PPB): | 99.80% |
Volume Distribution (VD): | 3.79 | Fu: | 1.78% |
CYP1A2-inhibitor: | 0.686 | CYP1A2-substrate: | 0.38 |
CYP2C19-inhibitor: | 0.354 | CYP2C19-substrate: | 0.105 |
CYP2C9-inhibitor: | 0.423 | CYP2C9-substrate: | 0.97 |
CYP2D6-inhibitor: | 0.17 | CYP2D6-substrate: | 0.688 |
CYP3A4-inhibitor: | 0.082 | CYP3A4-substrate: | 0.051 |
Clearance (CL): | 6.74 | Half-life (T1/2): | 0.682 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.197 |
Drug-inuced Liver Injury (DILI): | 0.03 | AMES Toxicity: | 0.025 |
Rat Oral Acute Toxicity: | 0.145 | Maximum Recommended Daily Dose: | 0.161 |
Skin Sensitization: | 0.947 | Carcinogencity: | 0.545 |
Eye Corrosion: | 0.877 | Eye Irritation: | 0.92 |
Respiratory Toxicity: | 0.898 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001656 | 0.542 | D03ZJE | 0.395 | ||||
ENC000275 | 0.517 | D05ATI | 0.384 | ||||
ENC001644 | 0.516 | D0O1PH | 0.379 | ||||
ENC000277 | 0.492 | D0I4DQ | 0.352 | ||||
ENC001655 | 0.492 | D0Z5SM | 0.350 | ||||
ENC000273 | 0.492 | D0Y8DP | 0.338 | ||||
ENC001588 | 0.476 | D0O1TC | 0.330 | ||||
ENC001685 | 0.471 | D0Z5BC | 0.324 | ||||
ENC000510 | 0.468 | D09ANG | 0.320 | ||||
ENC000267 | 0.466 | D0XN8C | 0.314 |